425: CoreWeave Details Proposed Core Scientific Acquisition and Associated Risks in SEC Filing

CoreWeave, Inc. has formally communicated its proposed acquisition of Core Scientific, Inc., outlining the required SEC filings and a comprehensive list of transaction-related risks.

Summary

• CoreWeave, Inc. is proposing to acquire Core Scientific, Inc.
• In connection with the proposed transaction, CoreWeave and Core Scientific will file relevant materials with the U.S. Securities and Exchange Commission (SEC), including a registration statement on Form S-4 by CoreWeave.
• The Form S-4 will include a proxy statement of Core Scientific that also constitutes a prospectus of CoreWeave.
• A definitive proxy statement/prospectus will be mailed to stockholders of Core Scientific.
• This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor a solicitation of any vote or approval.
• Investors and security holders are urged to read the registration statement, proxy statement/prospectus, and other relevant documents filed with the SEC carefully when they become available.
• Information about the directors and executive officers of both companies, who may be deemed participants in the proxy solicitation, is available in their respective prior SEC filings.

Sentiment

Score: 5

Explanation: The document is a standard, legally mandated disclosure for a proposed acquisition, primarily focused on procedural information and a comprehensive list of associated risks. Its tone is neutral and informational, not promotional or negative, reflecting its compliance purpose.

Risks

• The completion of the proposed transaction on anticipated terms, or at all, and the timing of completion, including obtaining required regulatory approvals and Core Scientific stockholder approval.
• Anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the combined company's operations, and other conditions to the completion of the proposed transaction.
• The possibility that any anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• The ability of CoreWeave and Core Scientific to integrate their businesses successfully and to achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.
• Disruptions from the proposed transaction harming CoreWeave's or Core Scientific's business, including current plans and operations, and diversion of management's time and attention to transaction-related issues.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and CoreWeave's and Core Scientific's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries, and changes in local, national, or international laws, regulations, and policies affecting CoreWeave and Core Scientific.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction that could affect financial performance and operating results.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions or otherwise operate its business.
• Acts of terrorism or outbreak of war, hostilities, civil unrest, attacks against CoreWeave or Core Scientific, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• The impacts of pandemics or other public health crises, including the effects of government responses on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.

Future Outlook

The document contains forward-looking statements regarding the consummation of the proposed transaction and its anticipated benefits, but these are subject to significant risks and uncertainties. It highlights the ambition for successful integration and value creation for the combined company, but does not provide specific financial guidance or projections.

Industry Context

The proposed acquisition involves companies operating in the artificial intelligence, power, data center, and crypto mining industries. A key strategic element mentioned is the potential conversion of crypto mining facilities into high-performance computing sites, reflecting a broader industry trend towards AI infrastructure.

Legal Proceedings

• Potential litigation relating to the proposed transaction could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.

Stakeholder Impact

• Shareholders of CoreWeave may experience dilution due to the issuance of additional shares in connection with the transaction.
• Business relationships of both CoreWeave and Core Scientific may experience adverse reactions or changes resulting from the announcement or completion of the proposed transaction.
• Management's time and attention will be diverted to transaction-related issues, potentially impacting current plans and operations.

Next Steps

• CoreWeave and Core Scientific will file a registration statement on Form S-4 with the SEC, which will include a proxy statement/prospectus.
• A definitive proxy statement/prospectus will be mailed to stockholders of Core Scientific.
• Core Scientific stockholder approval for the proposed transaction is required.
• Regulatory approvals may be required for the transaction to complete.
• The consummation of the proposed transaction.

Key Dates

Keywords

CoreWeave, Core Scientific, acquisition, merger, SEC filing, Form 425, S-4, proxy statement, prospectus, data center, crypto mining, high-performance computing, artificial intelligence, corporate transaction